Ann Arbor, MI, United States of America

Vladimir L Makarov

This inventor holds 44 USPTO granted patents and 14 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Nucleic Acid Amplification. Top assignees: Rubicon Genomics, Inc., Swift Biosciences, Inc., Takara Bio USA, Inc.. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir L Makarov. Retrieved from https://idiyas.com/inventor/vladimir-l-makarov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 44 

% Patents Active = 77.3

 

 

Average Co-Inventor Count = 2.5

ph-index = 12

Forward Citations = 750(Granted Patents)


Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
NGS Library Concentration
Targeted Amplification
Homopolymer Tailing
Whole Genome Analysis
Multiplex PCR
Adapter Ligation
DNA Sequencing
Nucleic Acid Molecules
Stem-Loop Oligonucleotides
DNA Libraries
Methylation Detection
Polynucleotide Isolation
44 patents (USPTO):Explore Patents

Title: Innovations by Vladimir L Makarov: A Pioneer in Nucleic Acid Research

Introduction: Vladimir L Makarov, based in Ann Arbor, MI, is an accomplished inventor with an impressive portfolio of 42 patents. His contributions to the field of nucleic acid research have made significant impacts, particularly in the realms of substrate polynucleotides and next-generation sequencing (NGS) methodologies.

Latest Patents: Two of Makarov's latest patents exhibit his innovative approach to nucleic acid manipulation. The first patent, titled "Methods and compositions for size-controlled homopolymer tailing of substrate polynucleotides by a nucleic acid polymerase," focuses on methods for adding tails of specific lengths to substrate polynucleotides. It also details techniques for immobilizing these tailed substrates onto solid supports. The second patent addresses "Normalization of NGS library concentration." This invention provides solutions to a significant bottleneck in the NGS workflow by enabling the accurate quantification of libraries for more efficient pooling and loading onto sequencing instruments.

Career Highlights: Throughout his career, Makarov has demonstrated excellence in research and innovation. He has worked with notable companies such as Rubicon Genomics, Inc. and Swift Biosciences, Inc., where he contributed to advancements in genomic technologies that enhance research capabilities.

Collaborations: Makarov has collaborated with fellow innovators, including Emmanuel Kamberov and Brendan J Tarrier. Their collective efforts have further advanced the understanding and application of nucleic acid technologies.

Conclusion: Vladimir L Makarov stands out as a key figure in the field of innovations related to nucleic acids. His ongoing efforts and significant contributions continue to push the boundaries of research and technology, inspiring future advancements in genetic and genomic sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…